Quantcast

Latest Glycosides Stories

2010-12-09 07:00:00

CHICAGO, Dec. 9, 2010 /PRNewswire/ -- PureCircle (LSE: PURE) the world's leading producer and marketer of high purity stevia products today confirms the continued expansion of its patent portfolio with the grant of three patents by the U.S. Patent and Trademark Office. The three patents cover a wide range of process and methods across PureCircle's entire stevia product portfolio and date back as early as December 21st, 2004, which pre-dates any other published patents relating to...

2010-12-08 07:07:00

BARTOW, Fla., Dec. 8, 2010 /PRNewswire/ -- Drinking orange juice every day may have important heart health benefits. A recent study published online in the American Journal of Clinical Nutrition found that consuming about two cups of 100 percent orange juice every day for one month significantly lowered diastolic blood pressure among men who were slightly overweight, but otherwise healthy.(1) Improvements also were seen in other indicators of cardiovascular health, notably better...

2010-12-04 00:00:40

SweetLeaf Stevia® Sweetener Recognized with 2010-2011 Global Stevia Products Award Gilbert, Arizona (Vocus) December 2, 2010 SweetLeaf Stevia® Sweetener was the overall winner of the 2010-2011 Annual Global Stevia Products Award by the International Society of Antioxidant in Nutrition and Health (ISANH) based on taste performance, advancement in ingredient science and positive environmental and social impact. SweetLeaf Stevia® founder and president, James May, was presented with...

2010-11-15 13:00:00

COLUMBIA, Md., Nov. 15, 2010 /PRNewswire-FirstCall/ -- Celsion Corporation (Nasdaq: CLSN), a biotechnology drug development company, today announced financial results for the third quarter and nine months ended September 30, 2010 and addressed the progress of its clinical trials of ThermoDox®, Celsion's proprietary heat-activated liposomal encapsulation of doxorubicin for the treatment of hepatocellular carcinoma (HCC), commonly referred to as primary liver cancer....

2010-11-10 06:30:00

XI'AN, China, Nov. 10, 2010 /PRNewswire-Asia-FirstCall/ -- Huifeng Bio-Pharmaceutical Technology, Inc. (OTC Bulletin Board: HFGB) ("the Company"), specializing in developing and producing botanical extracts and other raw materials for pharmaceuticals and food additives, today announced it entered into a $3.9 million USD Financing and Construction agreement with Xi'an Jucheng Investment & Consulting Co., Ltd. ("Jucheng"), a company organized and operating under the laws of the People's...

2010-10-28 07:30:00

FIVE POINTS, Calif., Oct. 28 /PRNewswire/ -- S&W Seed Company (Nasdaq: SANW) today provided a status report related to its progress in developing stevia leaf production in California on a commercial scale in support of U.S. demand for stevia leaf, the source of an all-natural, non-caloric sweetener used by major food and beverage manufacturers worldwide. S&W also announced that it has retained renowned stevia pioneer Clinton C. Shock, PhD to direct the Company's stevia plant...

2010-10-01 06:30:00

COLUMBIA, Md., Oct. 1 /PRNewswire/ -- Celsion Corporation (Nasdaq: CLSN) announced today that interim data from its Phase I/II DIGNITY trial of ThermoDox® in Recurrent Chest Wall (RCW) Breast Cancer were presented at the poster session at the 2010 Breast Cancer Symposium. The abstract provided updated clinical results from the 40 mg/m2 dose cohort. Additionally the company announced that the 50 mg/m2 dose cohort has now completed enrollment. This DIGNITY study...

2010-09-21 06:30:00

COLUMBIA, Md., Sept. 21 /PRNewswire/ -- Celsion Corporation (Nasdaq: CLSN) announced today that an abstract on its Phase I/II DIGNITY trial of ThermoDox® in Recurrent Chest Wall (RCW) Breast Cancer has been accepted for a poster session at the 2010 Breast Cancer Symposium. The abstract will provide updated clinical results, as well as the rationale and design of the DIGNITY study, which is evaluating ThermoDox in combination with microwave hyperthermia in women with RCW...

68ab31d35e95f06fd7c84f6ce924b1f31
2010-09-15 09:29:59

Scientists at the University of East Anglia (UEA) are launching a groundbreaking new project to investigate the benefits of broccoli in the fight against osteoarthritis. Initial laboratory research at UEA has found that a compound in broccoli called sulforaphane blocks the enzymes that cause joint destruction in osteoarthritis "“ the most common form of arthritis. Broccoli has previously been associated with reduced cancer risk but this is the first major study into its effects on joint...

2010-09-02 13:15:00

COLUMBIA, Md., Sept. 2 /PRNewswire-FirstCall/ --Celsion Corporation (Nasdaq: CLSN), a biotechnology drug development company, announced today that it has been awarded a competitive Phase I Small Business Innovation and Research (SBIR) grant from the National Institutes of Health (NIH), to support the proposal, "New Thermal Sensitive Carboplatin Liposomes for Cancer". This funding will support the Company's efforts to develop its proprietary heat-activated liposomal technology in...


Latest Glycosides Reference Libraries

45_20138aaa34c0aef5a2af87b137102229
2009-04-23 11:07:34

Bittercress (Barbarea vulgaris), also commonly known as Herb Barbara, Rocketcress, Yellow Rocketcress, Winter Rocket, and Wound Rocket, is a European biennial herb. This plant displays a rosette of shiny, dark green leaves at the base and additional pinnately divided leaves on the stem. In the spring, yellow flowers originate in tightly packed terminal groups just above the foliage. Bittercress grows wildly as a weed in many parts of North America. The flowers can be in bloom May...

More Articles (1 articles) »
Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related